<DOC>
	<DOC>NCT01334853</DOC>
	<brief_summary>The rationale for conducting this study is to explore potential clinical and peripheral biomarkers in subjects requiring daily medium to high dose inhaled corticosteroids for persistent asthma</brief_summary>
	<brief_title>A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Age 18 through 75 at the time of screening Written informed consent and any locally required authorization obtained from the subject prior to performing any protocolrelated procedures, including screening evaluations History of physiciandiagnosed asthma for at least 12 months prior to screening Stable Medium to highdose ICS divided twice daily as outlined by the NHLBI Asthma Guidelines, 2007 Any medical condition that, in the opinion of the investigator or medical monitor, would interfere with interpretation of subject safety or study results Concurrent enrollment in another clinical study Use of immunosuppressive medication within 3 months prior to screening Acute upper or lower respiratory infections requiring antibiotics or antiviral medications with in 30 days prior to screening or during screning period. Receipt of immunoglobulin or blood products within 30 days prior to screening or during the screening period Receipt of any investigational nonbiological drug therapy within 30 days or 5 halflives prior to screening whichever is longer; or receipt of any marketed or investigational biologic within 6 months or 5 halflives prior to screening whichever is longer Pregnant, lactating, or breastfeeding woman Diagnosis of lung disease other than persistent asthma History of smoking â‰¥10 pack years or any smoking within 12 months prior to screening History of active, infectious hepatitis A, B, C or human immunodeficiency virus (HIV)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>